COSCIENS Biopharma Inc. Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill
COSCIENS Biopharma Inc. (CSCIF) reported Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill of $372.00 thousand for the 12-month period ending 2022-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill · last filed 2024-07-17
| Period end | Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill 12 month | Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill 12 month as first filed |
|---|---|---|
| 2022-12-31 | $372.00K 20-F/A · filed 2024-07-17 | $7.64M 20-F · filed 2023-03-23 |
| 2021-12-31 | $372.00K 20-F/A · filed 2024-02-15 |